NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial

  1. Zhiguo Fan
  2. Duocai Li
  3. Shi Yan
  4. Xianzhi Zhao
  5. Lei Yin
  6. Weidong Xu
  7. Ye Wang
  8. Huojun Zhang
  9. Yifan Chang
  10. Shancheng Ren
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1186/s12885-024-13201-w
  2. Version published to 10.21203/rs.3.rs-4894517/v1 on Research Square